Quality Gap in Long-Stay Antipsychotic Quality Measure Performance Widens Over the Pandemic, Reversing Past Gains.

Autor:	Winter JD; Department of Family Medicine & Population Health, Virginia Commonwealth University School of Medicine, Richmond, USA.; Shenandoah Valley Family Practice Residency, Front Royal, VA, USA., Petterson S; Department of Family Medicine & Population Health, Virginia Commonwealth University School of Medicine, Richmond, USA., Qato DM; University of Maryland School of Pharmacy, Baltimore, USA.; Peter Lamy Center on Drug Therapy & Aging, Baltimore, USA., Kerns JW; Department of Family Medicine & Population Health, Virginia Commonwealth University School of Medicine, Richmond, USA.; Shenandoah Valley Family Practice Residency, Front Royal, VA, USA., Sabo RT; Department of Family Medicine & Population Health, Virginia Commonwealth University School of Medicine, Richmond, USA.; Department of Biostatistics, Virginia Commonwealth University School of Medicine, Richmond, USA., Winter KM; Shenandoah University School of Nursing, Winchester, VA, USA., Brandt N; University of Maryland School of Pharmacy, Baltimore, USA.; Peter Lamy Center on Drug Therapy & Aging, Baltimore, USA., Wastila L; University of Maryland School of Pharmacy, Baltimore, USA.; Peter Lamy Center on Drug Therapy & Aging, Baltimore, USA., Chung Y; Department of Family Medicine & Population Health, Virginia Commonwealth University School of Medicine, Richmond, USA.; Harvey L. Neiman Health Policy Institute, Reston, VA, USA., Funk A; Department of Family Medicine & Population Health, Virginia Commonwealth University School of Medicine, Richmond, USA.; Department of Biostatistics, Virginia Commonwealth University School of Medicine, Richmond, USA., Ewasiuk C; Department of Family Medicine & Population Health, Virginia Commonwealth University School of Medicine, Richmond, USA., Etz R; Department of Family Medicine & Population Health, Virginia Commonwealth University School of Medicine, Richmond, USA.; Larry A. Green Center, Richmond, VA, USA., Krist AH; Department of Family Medicine & Population Health, Virginia Commonwealth University School of Medicine, Richmond, USA.
Jazyk:	angličtina
Zdroj:	Gerontology & geriatric medicine [Gerontol Geriatr Med] 2024 Jun 18; Vol. 10, pp. 23337214241262914. Date of Electronic Publication: 2024 Jun 18 (Print Publication: 2024).
DOI:	10.1177/23337214241262914
Abstrakt:	The Centers for Medicare & Medicaid Services (CMS) grades nursing home performance in antipsychotic prescribing quarterly, publishing findings as a quality measure. While scores have improved since 2011, marked performance variation between facilities persists. To assess quality gap changes between best- and worst-performing deciles, we compared quarterly prescribing changes between these groups pre-pandemic (April 2011 to March 2020) and during the pandemic (April 2020 to March 2022). Antipsychotic quality measure scores, improving pre-pandemic, deteriorated during the pandemic. The pre-pandemic quality gap between the best- and worst-performing deciles narrowed as the worst-performing decile improved faster than the best-performing decile. During the pandemic, the quality gap widened as the worst-performing decile relapsed more than the best-performing decile ( p  < .0001). The pandemic disrupted quality performance gains and compounded disparities between facilities. A better understanding of the factors allowing high performers to weather pandemic stressors better than poor performers may reveal opportunities to improve nursing home quality and equity for all residents. Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. (© The Author(s) 2024.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu